Sorafenib Completed Phase 1 Trials for Urethral Cancer / Renal Pelvis Cancer / Cancer, Bladder / Transitional Cell Carcinoma / Ureteral Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01844947Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract